Passage Bio, Inc. has announced a merger with Remix Therapeutics, enhancing its position in the biological products sector.
| Name | Passage BIO, Inc. |
|---|---|
| CIK | 0001787297 |
| Tickers | PASG |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 822729751 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 2678660312 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Passage Bio, Inc. has announced a merger with Remix Therapeutics, enhancing its position in the biological products sector.
Passage BIO, Inc. shares new data from its Phase 1 trial of REM-422 for adenoid cystic carcinoma, emphasizing its commitment to innovative cancer therapies.
Passage Bio, Inc. is at risk of delisting from Nasdaq due to low stockholders' equity but plans to merge with Remix Therapeutics to regain compliance.
Passage BIO, Inc. releases its Q3 financial results, showcasing advancements in its biological products and ongoing projects.
Passage Bio, Inc. stockholders approve new equity incentive and employee stock purchase plans, contingent on the merger with Remix Therapeutics.
447 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | 8-K | 8-K | 8.01,9.01 | 0001140361-26-044947 | 001-39231 | 261576159 | 34 | 1892218 | 1 | 1 |
| 2026-11-19 | 8-K | 8-K | 7.01,9.01 | 0001140361-26-044811 | 001-39231 | 261572312 | 34 | 183900 | 1 | 1 |
| 2026-11-18 | 8-K | 8-K | 3.01 | 0001140361-26-044734 | 001-39231 | 261570687 | 34 | 153741 | 1 | 1 |
| 2026-11-10 | 10-Q | 10-Q | 0001104659-26-124783 | 001-39231 | 261537935 | 34 | 5752174 | 1 | 1 | |
| 2026-11-06 | 8-K | 8-K | 5.02,5.07,9.01 | 0001140361-26-042222 | 001-39231 | 261529185 | 34 | 246466 | 1 | 1 |
| 2026-10-09 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003198 | 333-297601 | 261454224 | 33 | 1809 | ||
| 2026-10-09 | 424B3 | 424B3 | 0001140361-26-039280 | 333-297601 | 261453417 | 33 | 17314598 | |||
| 2026-10-08 | S-4/A | S-4/A | 0001140361-26-039151 | 333-297601 | 261450446 | 33 | 17501160 | |||
| 2026-10-05 | S-4/A | S-4/A | 0001140361-26-038646 | 333-297601 | 261441196 | 33 | 17377238 | |||
| 2026-09-21 | S-4/A | S-4/A | 0001140361-26-037256 | 333-297601 | 261394799 | 33 | 17892814 | |||
| 2026-09-03 | S-4/A | S-4A | 0001140361-26-035517 | 333-297601 | 261356547 | 33 | 36599124 | 1 | 1 | |
| 2026-09-03 | 425 | 425 | 0001140361-26-035516 | 001-39231 | 261356541 | 34 | 2761206 | |||
| 2026-09-03 | 8-K | 8-K | 1.01,3.02,9.01 | 0001140361-26-035515 | 001-39231 | 261356538 | 34 | 3278882 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902664-26-003492 | 005-91451 | 261281200 | 34 | 10343 | |||
| 2026-08-10 | 10-Q | 10-Q | 0001104659-26-093021 | 001-39231 | 261256191 | 34 | 5779223 | 1 | 1 | |
| 2026-07-22 | 425 | 425 | 0001140361-26-029196 | 001-39231 | 261191554 | 34 | 15427435 | |||
| 2026-07-21 | S-4 | S-4 | 0001140361-26-029162 | 333-297601 | 261191135 | 33 | 37142787 | 1 | 1 | |
| 2026-07-02 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0000902664-26-003000 | 005-91451 | 261153934 | 34 | 30580 | |||
| 2026-06-29 | 4 | xslF345X06/ownership.xml | 0000902664-26-002945 | 8179 | ||||||
| 2026-06-25 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001957912-26-000025 | 005-91451 | 261123440 | 34 | 17804 | |||
| 2026-06-24 | 425 | 425 | 0001104659-26-077350 | 001-39231 | 261116787 | 34 | 36570 | |||
| 2026-06-24 | 425 | 425 | 0001104659-26-077312 | 001-39231 | 261116055 | 34 | 12018732 | |||
| 2026-06-24 | 8-K | FORM 8-K | 1.01,1.02,3.02,5.01,5.02,7.01,8.01,9.01 | 0001104659-26-077306 | 001-39231 | 261116034 | 34 | 12543686 | 1 | 1 |
| 2026-05-27 | 8-K | 8-K | 1.02 | 0001104659-26-066956 | 001-39231 | 261026355 | 34 | 148660 | 1 | 1 |
| 2026-05-26 | 8-K | FORM 8-K | 5.07 | 0001104659-26-065991 | 001-39231 | 261015918 | 34 | 208969 | 1 | 1 |
| 2026-05-21 | 4 | xslF345X06/form4-05212026_080510.xml | 0001986720-26-000002 | 5730 | ||||||
| 2026-05-21 | 4 | xslF345X06/form4-05212026_080536.xml | 0001706400-26-000002 | 5743 | ||||||
| 2026-05-21 | 4 | xslF345X06/form4-05212026_080558.xml | 0001303811-26-000002 | 5746 | ||||||
| 2026-05-21 | 4 | xslF345X06/form4-05212026_080513.xml | 0001677141-26-000006 | 5706 | ||||||
| 2026-05-21 | 4 | xslF345X06/form4-05212026_080523.xml | 0001280044-26-000002 | 5704 | ||||||
| 2026-05-21 | 4 | xslF345X06/form4-05212026_080534.xml | 0001571469-26-000002 | 5745 | ||||||
| 2026-05-12 | 10-Q | 10-Q | 0001104659-26-058987 | 001-39231 | 26965815 | 34 | 5322254 | 1 | 1 | |
| 2026-04-28 | 8-K | FORM 8-K | 2.05 | 0001104659-26-049755 | 001-39231 | 26903071 | 34 | 193902 | 1 | 1 |
| 2026-04-20 | 8-K | FORM 8-K | 7.01,9.01 | 0001104659-26-045219 | 001-39231 | 26873348 | 34 | 6241018 | 1 | 1 |
| 2026-04-07 | ARS | ARS | 0001104659-26-040132 | 001-39231 | 26842890 | 34 | 26288010 | |||
| 2026-04-07 | DEFA14A | DEFA14A | 0001104659-26-040131 | 001-39231 | 26842889 | 34 | 373104 | |||
| 2026-04-07 | DEF 14A | DEF 14A | 0001104659-26-040130 | 001-39231 | 26842884 | 34 | 2395529 | 1 | 1 | |
| 2026-03-18 | 4 | xslF345X06/form4-03182026_080313.xml | 0001987062-26-000002 | 5604 | ||||||
| 2026-03-18 | 4 | xslF345X06/form4-03182026_080328.xml | 0001949693-26-000002 | 12064 | ||||||
| 2026-03-10 | 8-K | FORM 8-K | 1.02 | 0001104659-26-025550 | 001-39231 | 26737188 | 34 | 192273 | 1 | 1 |
| 2026-03-04 | S-8 | FORM S-8 | 0001104659-26-023445 | 333-294006 | 26721153 | 33 | 211470 | 1 | 1 | |
| 2026-03-03 | 10-K | 10-K | 0001104659-26-022549 | 001-39231 | 26711040 | 34 | 10963979 | 1 | 1 | |
| 2026-03-03 | 8-K | 8-K | 2.02,7.01,9.01 | 0001104659-26-022539 | 001-39231 | 26710992 | 34 | 6225105 | 1 | 1 |
| 2026-01-12 | 4 | xslF345X05/form4-01122026_090148.xml | 0001949693-26-000001 | 9976 | ||||||
| 2026-01-12 | 4 | xslF345X05/form4-01122026_090110.xml | 0001987062-26-000001 | 9939 | ||||||
| 2026-01-12 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001104659-26-002696 | 001-39231 | 26524625 | 34 | 20719137 | 1 | 1 |
| 2026-01-09 | 144 | xsl144X01/primary_doc.xml | 0001970051-26-000002 | 001-39231 | 26523042 | 33 | 4709 | |||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_091215.xml | 0001987062-25-000002 | 5762 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12292025_091229.xml | 0001949693-25-000002 | 5745 | ||||||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-004968 | 005-91451 | 251484303 | 34 | 10631 | |||
| 2025-11-10 | 10-Q | 10-Q | 0001104659-25-109180 | 001-39231 | 251466734 | 34 | 7579014 | 1 | 1 | |
| 2025-11-10 | 8-K | 8-K | 2.02,7.01,9.01 | 0001104659-25-109158 | 001-39231 | 251466419 | 34 | 6386565 | 1 | 1 |
| 2025-09-18 | 8-K | FORM 8-K | 5.02 | 0001104659-25-091288 | 001-39231 | 251323841 | 34 | 193466 | 1 | 1 |
| 2025-09-15 | 4 | xslF345X05/ownership.xml | 0000902664-25-004079 | 12238 | ||||||
| 2025-08-12 | 10-Q | 10-Q | 0001558370-25-011146 | 001-39231 | 251204010 | 34 | 7651556 | 1 | 1 | |
| 2025-08-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-25-011143 | 001-39231 | 251203982 | 34 | 5128598 | 1 | 1 |
| 2025-07-29 | 8-K | FORM 8-K | 8.01 | 0001104659-25-071779 | 001-39231 | 251162724 | 34 | 194498 | 1 | 1 |
| 2025-07-24 | 4 | xslF345X05/ownership.xml | 0000902664-25-003152 | 12455 | ||||||
| 2025-07-24 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000947871-25-000684 | 005-91451 | 251148033 | 34 | 27663 | |||
| 2025-07-21 | 144 | xsl144X01/primary_doc.xml | 0000947871-25-000679 | 001-39231 | 251138173 | 33 | 14470 | |||
| 2025-07-21 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000947871-25-000678 | 005-91451 | 251138150 | 34 | 27821 | |||
| 2025-07-15 | 144 | xsl144X01/primary_doc.xml | 0000947871-25-000667 | 001-39231 | 251126019 | 33 | 13817 | |||
| 2025-07-14 | 8-K | FORM 8-K | 3.03,5.03,8.01,9.01 | 0001104659-25-067561 | 001-39231 | 251120121 | 34 | 231086 | 1 | 1 |
| 2025-07-09 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000947871-25-000657 | 005-91451 | 251114619 | 34 | 27227 | |||
| 2025-07-07 | 144 | xsl144X01/primary_doc.xml | 0000947871-25-000648 | 001-39231 | 251109136 | 33 | 11166 | |||
| 2025-06-26 | 4 | xslF345X05/ownership.xml | 0000947871-25-000629 | 11532 | ||||||
| 2025-06-24 | 144 | xsl144X01/primary_doc.xml | 0000947871-25-000628 | 001-39231 | 251070464 | 33 | 8678 | |||
| 2025-06-23 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-25-061371 | 001-39231 | 251062944 | 34 | 6604800 | 1 | 1 |
| 2025-05-30 | 4 | xslF345X05/form4-05312025_010556.xml | 0001415889-25-015077 | 12063 | ||||||
| 2025-05-30 | 4 | xslF345X05/form4-05302025_110508.xml | 0001415889-25-015059 | 11935 | ||||||
| 2025-05-30 | 4 | xslF345X05/form4-05302025_110515.xml | 0001415889-25-015058 | 12114 | ||||||
| 2025-05-30 | 4 | xslF345X05/form4-05302025_110521.xml | 0001415889-25-015057 | 12100 | ||||||
| 2025-05-30 | 4 | xslF345X05/form4-05302025_110532.xml | 0001415889-25-015056 | 12064 | ||||||
| 2025-05-30 | 4 | xslF345X05/form4-05302025_110538.xml | 0001415889-25-015055 | 12090 | ||||||
| 2025-05-30 | 4 | xslF345X05/form4-05302025_110528.xml | 0001415889-25-015054 | 5608 | ||||||
| 2025-05-30 | 8-K | FORM 8-K | 5.07 | 0001104659-25-054907 | 001-39231 | 251011362 | 34 | 205376 | 1 | 1 |
| 2025-05-13 | 10-Q | 10-Q | 0001558370-25-007489 | 001-39231 | 25937119 | 34 | 6965209 | 1 | 1 | |
| 2025-05-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-25-007487 | 001-39231 | 25937076 | 34 | 6600090 | 1 | 1 |
| 2025-04-25 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000947871-25-000425 | 005-91451 | 25875677 | 34 | 27035 | |||
| 2025-04-24 | 4 | xslF345X05/ownership.xml | 0000947871-25-000423 | 11527 | ||||||
| 2025-04-17 | 4 | xslF345X05/ownership.xml | 0000947871-25-000415 | 11527 | ||||||
| 2025-04-16 | ARS | ARS | 0001558370-25-004879 | 001-39231 | 25841202 | 34 | 8337546 | |||
| 2025-04-16 | DEFA14A | DEFA14A | 0001558370-25-004878 | 001-39231 | 25841199 | 34 | 374126 | |||
| 2025-04-16 | DEF 14A | DEF 14A | 0001558370-25-004877 | 001-39231 | 25841195 | 34 | 1585550 | 1 | 1 | |
| 2025-04-15 | 144 | xsl144X01/primary_doc.xml | 0000947871-25-000393 | 001-39231 | 25840749 | 33 | 4977 | |||
| 2025-04-04 | PRE 14A | PRE 14A | 0001558370-25-004441 | 001-39231 | 25812047 | 34 | 1517425 | 1 | 1 | |
| 2025-03-18 | 4 | xslF345X05/form4-03182025_090317.xml | 0001415889-25-008443 | 5560 | ||||||
| 2025-03-18 | 4 | xslF345X05/form4-03182025_090335.xml | 0001415889-25-008442 | 5543 | ||||||
| 2025-03-18 | 4 | xslF345X05/form4-03182025_090302.xml | 0001415889-25-008441 | 5573 | ||||||
| 2025-03-05 | 424B5 | 424B5 | 0001104659-25-020562 | 333-277632 | 25708637 | 33 | 45114 | |||
| 2025-03-05 | S-8 | FORM S-8 | 0001104659-25-020555 | 333-285549 | 25708611 | 33 | 95380 | |||
| 2025-03-04 | 10-K | 10-K | 0001558370-25-002101 | 001-39231 | 25701536 | 34 | 10406457 | 1 | 1 | |
| 2025-03-04 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-25-002093 | 001-39231 | 25701477 | 34 | 6567691 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-000982 | 005-91451 | 25623717 | 34 | 10528 | |||
| 2025-02-12 | 4 | xslF345X05/form4-02122025_090233.xml | 0001415889-25-003728 | 9933 | ||||||
| 2025-01-31 | 8-K | FORM 8-K | 3.01 | 0001104659-25-008100 | 001-39231 | 25578401 | 34 | 205802 | 1 | 1 |
| 2025-01-14 | 4 | xslF345X05/ownership.xml | 0000947871-25-000034 | 12933 | ||||||
| 2025-01-10 | 8-K | FORM 8-K | 2.02,2.05,2.06,7.01,8.01,9.01 | 0001104659-25-002278 | 001-39231 | 25520340 | 34 | 280594 | 1 | 1 |
| 2025-01-08 | 4 | xslF345X05/ownership.xml | 0000947871-25-000021 | 12932 | ||||||
| 2025-01-06 | 144 | xsl144X01/primary_doc.xml | 0000947871-25-000010 | 001-39231 | 25512042 | 33 | 8686 | |||
| 2024-12-31 | 4 | xslF345X05/ownership.xml | 0000902664-24-007075 | 7871 | ||||||
| 2024-12-26 | 4 | xslF345X05/ownership.xml | 0000947871-24-001037 | 8163 | ||||||
| 2024-12-26 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000947871-24-001036 | 005-91451 | 241581410 | 34 | 31163 | |||
| 2024-12-11 | 4 | xslF345X05/ownership.xml | 0000947871-24-000998 | 12466 | ||||||
| 2024-12-06 | 4 | xslF345X05/ownership.xml | 0000947871-24-000995 | 10781 | ||||||
| 2024-12-04 | 144 | xsl144X01/primary_doc.xml | 0000947871-24-000981 | 001-39231 | 241527401 | 33 | 7593 | |||
| 2024-12-04 | 144 | xsl144X01/primary_doc.xml | 0000947871-24-000980 | 001-39231 | 241527391 | 33 | 7478 | |||
| 2024-11-27 | 4 | xslF345X05/ownership.xml | 0000902664-24-006799 | 12232 | ||||||
| 2024-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001398344-24-020926 | 005-91451 | 241464405 | 34 | 6788 | |||
| 2024-11-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001398344-24-020911 | 005-91451 | 241464002 | 34 | 6595 | |||
| 2024-11-14 | SC 13G | PASSAGE BIO, INC. | 0000902664-24-006563 | 005-91451 | 241459142 | 34 | 67279 | |||
| 2024-11-13 | 10-Q | 10-Q | 0001558370-24-015431 | 001-39231 | 241451162 | 34 | 11672903 | 1 | 1 | |
| 2024-11-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-24-015429 | 001-39231 | 241451114 | 34 | 6428207 | 1 | 1 |
| 2024-10-24 | 8-K | 8-K | 7.01,9.01 | 0001558370-24-013563 | 001-39231 | 241390676 | 34 | 3987776 | 1 | 1 |
| 2024-10-02 | 4 | xslF345X05/form4-10022024_081040.xml | 0001415889-24-024433 | 5553 | ||||||
| 2024-10-02 | 4 | xslF345X05/form4-10022024_081016.xml | 0001415889-24-024416 | 5561 | ||||||
| 2024-10-02 | 3 | xslF345X02/form3-10022024_081024.xml | 0001415889-24-024408 | 9644 | ||||||
| 2024-09-23 | 4 | xslF345X05/ownership.xml | 0000947871-24-000769 | 8628 | ||||||
| 2024-09-18 | 4 | xslF345X05/ownership.xml | 0000947871-24-000763 | 12469 | ||||||
| 2024-09-16 | 144 | xsl144X01/primary_doc.xml | 0000947871-24-000760 | 001-39231 | 241302318 | 33 | 4858 | |||
| 2024-09-16 | 144 | xsl144X01/primary_doc.xml | 0000947871-24-000759 | 001-39231 | 241302316 | 33 | 4951 | |||
| 2024-09-16 | 8-K | 8-K | 7.01,8.01,9.01 | 0001558370-24-012793 | 001-39231 | 241299298 | 34 | 7036879 | 1 | 1 |
| 2024-09-10 | 8-K | FORM 8-K | 5.02 | 0001104659-24-098371 | 001-39231 | 241288729 | 34 | 206998 | 1 | 1 |
| 2024-09-06 | 8-K | 8-K | 2.06 | 0001558370-24-012654 | 001-39231 | 241284684 | 34 | 162446 | 1 | 1 |
| 2024-08-09 | SC 13D/A | SC 13D/A | 0001193125-24-198056 | 005-91451 | 241194339 | 34 | 66790 | |||
| 2024-08-09 | SC 13G/A | PASSAGE BIO, INC. | 0000902664-24-005050 | 005-91451 | 241193987 | 34 | 62882 | |||
| 2024-08-09 | 3 | xslF345X02/ownership.xml | 0000902664-24-005049 | 6395 | ||||||
| 2024-08-08 | 10-Q | 10-Q | 0001558370-24-011463 | 001-39231 | 241186026 | 34 | 7486432 | 1 | 1 | |
| 2024-08-08 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-24-011459 | 001-39231 | 241185939 | 34 | 6540718 | 1 | 1 |
| 2024-08-02 | 8-K | FORM 8-K | 3.01 | 0001104659-24-085360 | 001-39231 | 241170972 | 34 | 205186 | 1 | 1 |
| 2024-08-01 | 8-K | FORM 8-K | 1.01,2.02,5.02,7.01,9.01 | 0001104659-24-084615 | 001-39231 | 241164156 | 34 | 255779 | 1 | 1 |
| 2024-07-16 | 8-K | 8-K | 7.01,8.01,9.01 | 0001558370-24-009826 | 001-39231 | 241118578 | 34 | 205971 | 1 | 1 |
| 2024-05-29 | SC 13D/A | SC 13D/A | 0001193125-24-149241 | 005-91451 | 24999058 | 34 | 113635 | |||
| 2024-05-23 | 4 | xslF345X05/form4-05232024_090550.xml | 0001415889-24-014333 | 5606 | ||||||
| 2024-05-23 | 4 | xslF345X05/form4-05232024_080547.xml | 0001415889-24-014313 | 5443 | ||||||
| 2024-05-23 | 4 | xslF345X05/form4-05232024_080500.xml | 0001415889-24-014312 | 5567 | ||||||
| 2024-05-23 | 4 | xslF345X05/form4-05232024_080531.xml | 0001415889-24-014311 | 5574 | ||||||
| 2024-05-23 | 4 | xslF345X05/form4-05232024_080524.xml | 0001415889-24-014310 | 5591 | ||||||
| 2024-05-23 | 4 | xslF345X05/form4-05232024_080531.xml | 0001415889-24-014309 | 5604 | ||||||
| 2024-05-22 | 8-K | FORM 8-K | 5.07 | 0001104659-24-064243 | 001-39231 | 24973197 | 34 | 212332 | 1 | 1 |
| 2024-05-14 | 424B3 | 424B3 | 0001104659-24-060899 | 333-277632 | 24941544 | 33 | 456116 | |||
| 2024-05-14 | 10-Q | 10-Q | 0001558370-24-008058 | 001-39231 | 24941442 | 34 | 6836192 | 1 | 1 | |
| 2024-05-14 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-24-008054 | 001-39231 | 24941418 | 34 | 6819365 | 1 | 1 |
| 2024-04-16 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-04-16 16:00:00 | 9999999995-24-000982 | 333-277632 | 24849288 | 33 | 1815 | ||
| 2024-04-12 | CORRESP | filename1.htm | 0001104659-24-046858 | 11397 | ||||||
| 2024-04-12 | SC 13D/A | AMENDMENT NO. 4 | 0000947871-24-000373 | 005-91451 | 24842545 | 34 | 114737 | |||
| 2024-04-09 | DEFA14A | DEFA14A | 0001104659-24-045039 | 001-39231 | 24831395 | 34 | 848083 | |||
| 2024-04-09 | DEF 14A | DEF 14A | 0001104659-24-044915 | 001-39231 | 24831048 | 34 | 1066723 | |||
| 2024-04-09 | ARS | ARS | 0001104659-24-044912 | 001-39231 | 24831043 | 34 | 3927119 | |||
| 2024-03-29 | SC 13G | PASSAGE BIO, INC. | 0000902664-24-002687 | 005-91451 | 24804272 | 34 | 65844 | |||
| 2024-03-19 | 4 | xslF345X05/form4-03192024_080352.xml | 0001415889-24-008495 | 5554 | ||||||
| 2024-03-19 | 4 | xslF345X05/form4-03192024_080347.xml | 0001415889-24-008491 | 5562 | ||||||
| 2024-03-19 | 4 | xslF345X05/form4-03192024_080351.xml | 0001415889-24-008489 | 5555 | ||||||
| 2024-03-19 | 4 | xslF345X05/form4-03192024_080350.xml | 0001415889-24-008487 | 5549 | ||||||
| 2024-03-07 | UPLOAD | filename1.pdf | 0000000000-24-002537 | 333-277632 | 40397 | |||||
| 2024-03-04 | S-8 | FORM S-8 | 0001104659-24-030519 | 333-277637 | 24715906 | 33 | 98127 | |||
| 2024-03-04 | S-3 | S-3 | 0001104659-24-030481 | 333-277632 | 24715043 | 33 | 1022119 | |||
| 2024-03-04 | 10-K | 10-K | 0001558370-24-002310 | 001-39231 | 24712831 | 34 | 10676466 | 1 | 1 | |
| 2024-03-04 | 8-K | 8-K | 2.02,5.02,7.01,9.01 | 0001558370-24-002309 | 001-39231 | 24712819 | 34 | 6611402 | 1 | 1 |
| 2024-02-29 | 8-K | FORM 8-K | 8.01 | 0001104659-24-029361 | 001-39231 | 24703590 | 34 | 201803 | 1 | 1 |
| 2024-02-14 | SC 13G/A | PASSAGE BIO, INC. | 0000902664-24-001612 | 005-91451 | 24633038 | 34 | 64996 | |||
| 2024-02-13 | 4 | xslF345X05/form4-02142024_120246.xml | 0001415889-24-003640 | 9097 | ||||||
| 2024-02-13 | 4 | xslF345X05/form4-02142024_120249.xml | 0001415889-24-003637 | 15977 | ||||||
| 2024-01-05 | 8-K | 8-K | 7.01,9.01 | 0001558370-24-000107 | 001-39231 | 24516261 | 34 | 6337532 | 1 | 1 |
| 2024-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-24-000369 | 9650 | ||||||
| 2024-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-24-000367 | 9615 | ||||||
| 2024-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-24-000365 | 9658 | ||||||
| 2023-12-29 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-23-130478 | 001-39231 | 231527845 | 34 | 305277 | 1 | 1 |
| 2023-12-20 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-23-127507 | 001-39231 | 231499364 | 34 | 274365 | 1 | 1 |
| 2023-11-13 | 10-Q | 10-Q | 0001558370-23-018686 | 001-39231 | 231395068 | 34 | 7251322 | 1 | 1 | |
| 2023-11-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-23-018679 | 001-39231 | 231394996 | 34 | 6998903 | 1 | 1 |
| 2023-11-09 | SC 13D/A | SC 13D/A | 0001193125-23-274641 | 005-91451 | 231393926 | 34 | 120679 | |||
| 2023-09-01 | 8-K | FORM 8-K | 3.01 | 0001104659-23-097755 | 001-39231 | 231232622 | 34 | 204010 | 1 | 1 |
| 2023-08-07 | 10-Q | 10-Q | 0001558370-23-013489 | 001-39231 | 231145575 | 34 | 6662157 | 1 | 1 | |
| 2023-08-07 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001558370-23-013486 | 001-39231 | 231145570 | 34 | 4726397 | 1 | 1 |
| 2023-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-043998 | 9247 | ||||||
| 2023-07-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-043872 | 5512 | ||||||
| 2023-07-31 | 3 | FORM 3 SUBMISSION | 0001209191-23-043861 | 6676 | ||||||
| 2023-07-31 | 8-K | FORM 8-K | 5.02 | 0001104659-23-085580 | 001-39231 | 231125022 | 34 | 206577 | 1 | 1 |
| 2023-07-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-043725 | 5581 | ||||||
| 2023-07-28 | 3 | FORM 3 SUBMISSION | 0001209191-23-043724 | 13490 | ||||||
| 2023-07-20 | 8-K | FORM_8K | 5.02,8.01 | 0001104659-23-082546 | 001-39231 | 231098058 | 34 | 209737 | 1 | 1 |
| 2023-06-29 | 4 | xslF345X04/ownership.xml | 0000947871-23-000712 | 9736 | ||||||
| 2023-06-29 | SC 13D/A | AMENDMENT NO. 3 | 0000947871-23-000711 | 005-91451 | 231057928 | 34 | 113717 | |||
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038345 | 9458 | ||||||
| 2023-06-15 | SC 13D/A | SC 13D/A | 0001193125-23-167517 | 005-91451 | 231016244 | 34 | 121249 | |||
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032571 | 5482 | ||||||
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032568 | 5531 | ||||||
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032565 | 5494 | ||||||
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032552 | 5515 | ||||||
| 2023-05-26 | 8-K | FORM 8-K | 5.07 | 0001104659-23-065493 | 001-39231 | 23969390 | 34 | 214357 | 1 | 1 |
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032546 | 5501 | ||||||
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032545 | 5350 | ||||||
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032542 | 5533 | ||||||
| 2023-05-11 | 10-Q | 10-Q | 0001558370-23-009256 | 001-39231 | 23908787 | 34 | 6311894 | 1 | 1 | |
| 2023-05-11 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-23-009253 | 001-39231 | 23908776 | 34 | 7748662 | 1 | 1 |
| 2023-04-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-024982 | 9427 | ||||||
| 2023-04-14 | ARS | ARS | 0001104659-23-045309 | 001-39231 | 23819731 | 34 | 52023699 | |||
| 2023-04-14 | DEFA14A | DEFA14A | 0001104659-23-045308 | 001-39231 | 23819729 | 34 | 383940 | |||
| 2023-04-14 | DEF 14A | DEF 14A | 0001104659-23-045305 | 001-39231 | 23819727 | 34 | 874201 | |||
| 2023-04-06 | 8-K | 8-K | 1.01 | 0001558370-23-005571 | 001-39231 | 23806560 | 34 | 165982 | 1 | 1 |
| 2023-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-023481 | 5528 | ||||||
| 2023-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-023479 | 5532 | ||||||
| 2023-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-023478 | 5534 | ||||||
| 2023-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-023477 | 5521 | ||||||
| 2023-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-023476 | 5550 | ||||||
| 2023-04-03 | PRE 14A | PRE 14A | 0001104659-23-040826 | 001-39231 | 23792611 | 34 | 900416 | |||
| 2023-03-10 | 8-K | FORM 8-K | 7.01 | 0001104659-23-031221 | 001-39231 | 23724292 | 34 | 202749 | 1 | 1 |
| 2023-03-06 | S-8 | FORM S-8 | 0001104659-23-028902 | 333-270293 | 23708357 | 33 | 397233 | |||
| 2023-03-06 | 10-K | 10-K | 0001558370-23-002833 | 001-39231 | 23707538 | 34 | 9338883 | 1 | 1 | |
| 2023-03-06 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-23-002831 | 001-39231 | 23707517 | 34 | 7587789 | 1 | 1 |
| 2023-02-24 | 8-K | 8-K | 7.01,9.01 | 0001558370-23-001964 | 001-39231 | 23662309 | 34 | 3205407 | 1 | 1 |
| 2023-02-14 | SC 13G/A | PASSAGE BIO, INC. | 0000902664-23-001802 | 005-91451 | 23629037 | 34 | 66450 | |||
| 2023-02-14 | SC 13G/A | deeptrack-pasg123122a2.htm | 0001172661-23-000850 | 005-91451 | 23623065 | 34 | 102980 | |||
| 2023-01-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-23-000123 | 001-39231 | 23516512 | 34 | 7186906 | 1 | 1 |
| 2022-12-14 | 8-K | 8-K | 7.01,9.01 | 0001558370-22-018617 | 001-39231 | 221461120 | 34 | 4883512 | 1 | 1 |
| 2022-12-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-059462 | 5236 | ||||||
| 2022-12-02 | 8-K | FORM 8-K | 5.03,9.01 | 0001104659-22-124102 | 001-39231 | 221442099 | 34 | 471801 | 1 | 1 |
| 2022-11-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-058795 | 10063 | ||||||
| 2022-11-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-057891 | 9373 | ||||||
| 2022-11-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-056614 | 5624 | ||||||
| 2022-11-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-056613 | 5626 | ||||||
| 2022-11-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-056611 | 5613 | ||||||
| 2022-11-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-056609 | 5642 | ||||||
| 2022-11-10 | 10-Q | 10-Q | 0001558370-22-017285 | 001-39231 | 221374919 | 34 | 6981400 | 1 | 1 | |
| 2022-11-10 | 8-K | 8-K | 2.02,5.02,7.01,9.01 | 0001558370-22-017280 | 001-39231 | 221374863 | 34 | 6096544 | 1 | 1 |
| 2022-10-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-053454 | 5547 | ||||||
| 2022-10-12 | 3 | FORM 3 SUBMISSION | 0001209191-22-053453 | 6744 | ||||||
| 2022-10-11 | 8-K | FORM 8-K | 5.02 | 0001104659-22-107408 | 001-39231 | 221302313 | 34 | 209511 | 1 | 1 |
| 2022-09-29 | SC 13G | PASSAGE BIO, INC. | 0000902664-22-004380 | 005-91451 | 221280931 | 34 | 68856 | |||
| 2022-08-15 | SC 13D/A | SC 13D/A | 0001193125-22-220875 | 005-91451 | 221163666 | 34 | 132882 | |||
| 2022-08-11 | 8-K | FORM 8-K | 8.01 | 0001104659-22-088998 | 001-39231 | 221153653 | 34 | 199968 | 1 | 1 |
| 2022-08-04 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-22-012048 | 001-39231 | 221134669 | 34 | 7626258 | 1 | 1 |
| 2022-08-04 | 10-Q | 10-Q | 0001558370-22-012042 | 001-39231 | 221134657 | 34 | 6944164 | 1 | 1 | |
| 2022-07-08 | SC 13G | us7027121000_070822.txt | 0000834237-22-010173 | 005-91451 | 221074961 | 34 | 12390 | |||
| 2022-07-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-041401 | 5421 | ||||||
| 2022-07-06 | 3 | FORM 3 SUBMISSION | 0001209191-22-041400 | 6680 | ||||||
| 2022-07-06 | 8-K | 8-K | 5.02 | 0001558370-22-010548 | 001-39231 | 221067377 | 34 | 157943 | 1 | 1 |
| 2022-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-037060 | 5519 | ||||||
| 2022-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-037054 | 5500 | ||||||
| 2022-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-037053 | 5504 | ||||||
| 2022-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-037051 | 5493 | ||||||
| 2022-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-037050 | 5518 | ||||||
| 2022-06-08 | 8-K | FORM 8-K | 8.01 | 0001104659-22-069166 | 001-39231 | 221002595 | 34 | 201993 | 1 | 1 |
| 2022-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-033163 | 5263 | ||||||
| 2022-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-033158 | 5440 | ||||||
| 2022-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-033149 | 5490 | ||||||
| 2022-06-01 | 8-K | FORM 8-K | 5.02,5.07 | 0001104659-22-066896 | 001-39231 | 22986007 | 34 | 222985 | 1 | 1 |
| 2022-05-31 | 4 | FORM 4 SUBMISSION | 0001209191-22-032839 | 5450 | ||||||
| 2022-05-31 | 4 | FORM 4 SUBMISSION | 0001209191-22-032837 | 5499 | ||||||
| 2022-05-31 | 4 | FORM 4 SUBMISSION | 0001209191-22-032825 | 5462 | ||||||
| 2022-05-31 | 4 | FORM 4 SUBMISSION | 0001209191-22-032819 | 5469 | ||||||
| 2022-05-31 | 4 | FORM 4 SUBMISSION | 0001209191-22-032812 | 5318 | ||||||
| 2022-05-31 | 4 | FORM 4 SUBMISSION | 0001209191-22-032807 | 5501 | ||||||
| 2022-05-18 | 8-K | 8-K | 7.01,8.01,9.01 | 0001558370-22-009142 | 001-39231 | 22937034 | 34 | 3735306 | 1 | 1 |
| 2022-05-16 | 10-Q | 10-Q | 0001558370-22-008859 | 001-39231 | 22925466 | 34 | 6582625 | 1 | 1 | |
| 2022-05-16 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-22-008854 | 001-39231 | 22925420 | 34 | 7374979 | 1 | 1 |
| 2022-05-05 | 4 | xslF345X03/ownership.xml | 0000947871-22-000509 | 10372 | ||||||
| 2022-05-05 | 4/A | xslF345X03/ownership.xml | 0000947871-22-000507 | 8776 | ||||||
| 2022-05-05 | SC 13D/A | AMENDMENT NO. 2 | 0000947871-22-000506 | 005-91451 | 22897381 | 34 | 122217 | |||
| 2022-04-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-024942 | 5703 | ||||||
| 2022-04-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-024938 | 5547 | ||||||
| 2022-04-14 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001558370-22-002827,2022-04-14 | 9999999995-22-000975 | 333-253955 | 22828884 | 33 | 1779 | ||
| 2022-04-14 | DEFA14A | DEFA14A | 0001104659-22-046032 | 001-39231 | 22827453 | 34 | 354665 | |||
| 2022-04-14 | DEF 14A | DEF 14A | 0001104659-22-046024 | 001-39231 | 22827419 | 34 | 673406 | |||
| 2022-04-08 | 3 | FORM 3 SUBMISSION | 0001209191-22-023926 | 6746 | ||||||
| 2022-03-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-020791 | 8352 | ||||||
| 2022-03-15 | 8-K | FORM 8-K | 8.01 | 0001104659-22-033615 | 001-39231 | 22739099 | 34 | 201208 | 1 | 1 |
| 2022-03-11 | 8-K | FORM 8-K | 5.02 | 0001104659-22-032947 | 001-39231 | 22733907 | 34 | 201329 | 1 | 1 |
| 2022-03-10 | 8-K | FORM 8-K | 8.01 | 0001104659-22-032216 | 001-39231 | 22727382 | 34 | 200801 | 1 | 1 |
| 2022-03-03 | POS AM | POS AM | 0001558370-22-002827 | 333-253955 | 22710217 | 33 | 118513 | |||
| 2022-03-03 | S-8 | S-8 | 0001558370-22-002743 | 333-263252 | 22706858 | 33 | 177132 | |||
| 2022-03-03 | POS AM | POS AM | 0001558370-22-002736 | 333-253955 | 22706816 | 33 | 697749 | |||
| 2022-03-03 | 10-K | 10-K | 0001558370-22-002719 | 001-39231 | 22706747 | 34 | 8828585 | 1 | 1 | |
| 2022-03-03 | 8-K | 8-K | 2.02,9.01 | 0001558370-22-002717 | 001-39231 | 22706733 | 34 | 304616 | 1 | 1 |
| 2022-03-03 | POSASR | POSASR | 0001558370-22-002714 | 333-253955 | 22706708 | 33 | 792007 | |||
| 2022-02-14 | 4 | PRIMARY DOCUMENT | 0001787297-22-000006 | 5432 | ||||||
| 2022-02-14 | 4 | PRIMARY DOCUMENT | 0001787297-22-000005 | 9150 | ||||||
| 2022-02-14 | 4 | PRIMARY DOCUMENT | 0001787297-22-000004 | 10042 | ||||||
| 2022-02-14 | 4 | PRIMARY DOCUMENT | 0001787297-22-000003 | 5415 | ||||||
| 2022-02-14 | 4 | PRIMARY DOCUMENT | 0001787297-22-000002 | 5429 | ||||||
| 2022-02-14 | 4 | PRIMARY DOCUMENT | 0001787297-22-000001 | 6245 | ||||||
| 2022-02-14 | SC 13G/A | deeptrack-pasg123121a1.htm | 0001172661-22-000424 | 005-91451 | 22625847 | 34 | 103061 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001193125-22-039332 | 005-91451 | 22625079 | 34 | 92358 | |||
| 2022-02-11 | 8-K | 8-K | 7.01,8.01,9.01 | 0001558370-22-001039 | 001-39231 | 22617709 | 34 | 4753059 | 1 | 1 |
| 2022-02-09 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-22-006086 | 005-91451 | 22605334 | 34 | 93092 | |||
| 2022-02-04 | SC 13G | us7027121000_020422.txt | 0000834237-22-007116 | 005-91451 | 22593336 | 34 | 13443 | |||
| 2022-01-24 | 4 | xslF345X03/ownership.xml | 0000947871-22-000090 | 8157 | ||||||
| 2022-01-20 | 4 | xslF345X03/ownership.xml | 0000947871-22-000086 | 11815 | ||||||
| 2022-01-13 | 4 | xslF345X03/ownership.xml | 0000947871-22-000055 | 11815 | ||||||
| 2022-01-10 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001558370-22-000157 | 001-39231 | 22519742 | 34 | 6607776 | 1 | 1 |
| 2021-12-17 | 8-K | 8-K | 7.01,8.01,9.01 | 0001558370-21-016900 | 001-39231 | 211499469 | 34 | 4125603 | 1 | 1 |
| 2021-12-10 | 4 | FORM 4 SUBMISSION | 0001209191-21-069101 | 10791 | ||||||
| 2021-12-10 | SC 13G/A | filing.txt | 0000315066-21-001899 | 005-91451 | 211483778 | 34 | 8590 | |||
| 2021-11-04 | 10-Q | 10-Q | 0001558370-21-014460 | 001-39231 | 211378118 | 34 | 6692364 | 1 | 1 | |
| 2021-11-04 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-21-014458 | 001-39231 | 211378082 | 34 | 7517770 | 1 | 1 |
| 2021-11-01 | 8-K | 8-K | 5.02 | 0001558370-21-013927 | 001-39231 | 211368014 | 34 | 157141 | 1 | 1 |
| 2021-10-25 | SC 13G | deeptrack-pasg102221.htm | 0001172661-21-002057 | 005-91451 | 211344978 | 34 | 102980 | |||
| 2021-10-04 | 8-K | 8-K | 7.01,9.01 | 0001558370-21-012944 | 001-39231 | 211301013 | 34 | 7300116 | 1 | 1 |
| 2021-08-25 | 4 | FORM 4 SUBMISSION | 0001209191-21-053365 | 5580 | ||||||
| 2021-08-25 | 3 | FORM 3 SUBMISSION | 0001209191-21-053363 | 6733 | ||||||
| 2021-08-05 | 10-Q | 10-Q | 0001558370-21-010405 | 001-39231 | 211146402 | 34 | 6443215 | 1 | 1 | |
| 2021-08-05 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-21-010372 | 001-39231 | 211146232 | 34 | 2733493 | ||
| 2021-07-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-047616 | 8232 | ||||||
| 2021-07-21 | 3 | FORM 3 SUBMISSION | 0001209191-21-047615 | 6742 | ||||||
| 2021-07-21 | 8-K | 8-K | 5.02 | 0001558370-21-009027 | 001-39231 | 211102754 | 34 | 35142 | ||
| 2021-07-19 | S-8 | S-8 | 0001558370-21-008991 | 333-258000 | 211096885 | 33 | 476146 | |||
| 2021-06-09 | 3 | FORM 3 SUBMISSION | 0001209191-21-039270 | 9323 | ||||||
| 2021-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-036754 | 5263 | ||||||
| 2021-05-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-036630 | 5398 | ||||||
| 2021-05-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-036629 | 5417 | ||||||
| 2021-05-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-036628 | 5417 | ||||||
| 2021-05-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-036625 | 5410 | ||||||
| 2021-05-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-036622 | 5437 | ||||||
| 2021-05-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-036621 | 5427 | ||||||
| 2021-05-28 | 3 | FORM 3 SUBMISSION | 0001209191-21-036618 | 6656 | ||||||
| 2021-05-28 | 4 | FORM 4 SUBMISSION | 0001209191-21-036616 | 5449 | ||||||
| 2021-05-28 | 8-K | 8-K | 5.07 | 0001558370-21-007852 | 001-39231 | 21979967 | 34 | 39945 | ||
| 2021-05-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-035059 | 4808 | ||||||
| 2021-05-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-035051 | 4852 | ||||||
| 2021-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-21-034185 | 5726 | ||||||
| 2021-05-18 | 8-K | FORM 8-K | 5.02 | 0001104659-21-068911 | 001-39231 | 21936945 | 34 | 23334 | ||
| 2021-05-05 | 10-Q | 10-Q | 0001558370-21-005807 | 001-39231 | 21891234 | 34 | 5523252 | 1 | ||
| 2021-05-05 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-21-005788 | 001-39231 | 21891111 | 34 | 7730004 | ||
| 2021-04-14 | DEFA14A | DEFA14A | 0001558370-21-004269 | 001-39231 | 21825781 | 34 | 295680 | |||
| 2021-04-14 | DEF 14A | DEF 14A | 0001558370-21-004266 | 001-39231 | 21825694 | 34 | 902582 | |||
| 2021-03-29 | 4 | FORM 4 SUBMISSION | 0001209191-21-023476 | 10593 | ||||||
| 2021-03-29 | 3 | FORM 3 SUBMISSION | 0001209191-21-023475 | 6763 | ||||||
| 2021-03-22 | 8-K | 8-K | 5.02,8.01 | 0001558370-21-003287 | 001-39231 | 21759870 | 34 | 32252 | ||
| 2021-03-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-021616 | 15332 | ||||||
| 2021-03-05 | S-3ASR | S-3ASR | 0001104659-21-032832 | 333-253955 | 21719642 | 33 | 1308049 | |||
| 2021-03-05 | S-8 | S-8 | 0001558370-21-002454 | 333-253922 | 21718431 | 33 | 171774 | |||
| 2021-03-03 | 10-K | 10-K | 0001558370-21-002287 | 001-39231 | 21707267 | 34 | 8630289 | 1 | ||
| 2021-03-03 | 8-K | 8-K | 2.02,7.01,9.01 | 0001558370-21-002283 | 001-39231 | 21707198 | 34 | 7509041 | ||
| 2021-02-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-012828 | 9024 | ||||||
| 2021-02-22 | 3 | FORM 3 SUBMISSION | 0001209191-21-012825 | 6591 | ||||||
| 2021-02-19 | 8-K | 8-K | 5.02 | 0001558370-21-001301 | 001-39231 | 21656916 | 34 | 40264 | ||
| 2021-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-012170 | 5542 | ||||||
| 2021-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-012169 | 6351 | ||||||
| 2021-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-012160 | 5532 | ||||||
| 2021-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-012158 | 6370 | ||||||
| 2021-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-012156 | 6399 | ||||||
| 2021-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-012154 | 6401 | ||||||
| 2021-02-17 | 8-K | 8-K | 5.02 | 0001558370-21-001151 | 001-39231 | 21645795 | 34 | 40113 | ||
| 2021-02-12 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-21-009004 | 005-91451 | 21628151 | 34 | 79697 | |||
| 2021-02-11 | SC 13G | SC 13G | 0001193125-21-038695 | 005-91451 | 21620756 | 34 | 117865 | |||
| 2021-02-09 | SC 13G | SCHEDULE 13G | 0001213900-21-007749 | 005-91451 | 21606761 | 34 | 95638 | |||
| 2021-02-08 | SC 13G/A | filing.txt | 0000315066-21-001195 | 005-91451 | 21599742 | 34 | 8423 | |||
| 2021-01-28 | SC 13D/A | AMENDMENT NO. 1 | 0000947871-21-000111 | 005-91451 | 21563950 | 34 | 142557 | |||
| 2021-01-27 | SC 13D/A | SC 13D/A | 0001193125-21-019026 | 005-91451 | 21559256 | 34 | 99160 | |||
| 2021-01-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-004949 | 6319 | ||||||
| 2021-01-22 | 424B1 | 424B1 | 0001104659-21-006683 | 333-252213 | 21546182 | 33 | 10892689 | |||
| 2021-01-21 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-01-21 16:30:00 | 9999999995-21-000233 | 333-252213 | 21543667 | 33 | 1766 | ||
| 2021-01-19 | CORRESP | filename1.htm | 0001104659-21-005394 | 13433 | ||||||
| 2021-01-19 | CORRESP | filename1.htm | 0001104659-21-005393 | 12964 | ||||||
| 2021-01-19 | S-1 | S-1 | 0001104659-21-005296 | 333-252213 | 21535459 | 33 | 20041394 | 1 | ||
| 2021-01-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-003921 | 10250 | ||||||
| 2021-01-11 | 8-K | FORM 8-K | 7.01,9.01 | 0001104659-21-002688 | 001-39231 | 21519112 | 34 | 8502201 | ||
| 2020-12-22 | UPLOAD | filename1.pdf | 0000000000-20-012344 | 40615 | ||||||
| 2020-12-18 | DRS | filename1.htm | 0001104659-20-137415 | 377-03911 | 201400662 | 33 | 11443410 | |||
| 2020-12-18 | 8-K | FORM 8-K | 1.01,9.01 | 0001104659-20-137129 | 001-39231 | 201397990 | 34 | 435935 | ||
| 2020-11-10 | 10-Q | 10-Q | 0001558370-20-013472 | 001-39231 | 201299672 | 34 | 5660360 | 1 | ||
| 2020-11-10 | 8-K | 8-K | 2.02,9.01 | 0001558370-20-013468 | 001-39231 | 201299590 | 34 | 214703 | ||
| 2020-09-09 | 8-K | FORM 8-K | 7.01,9.01 | 0001104659-20-103244 | 001-39231 | 201165374 | 34 | 3864253 | ||
| 2020-08-13 | 10-Q | 10-Q | 0001558370-20-010495 | 001-39231 | 201097290 | 34 | 4878850 | 1 | ||
| 2020-08-13 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-20-094318 | 001-39231 | 201097196 | 34 | 107859 | ||
| 2020-06-10 | SC 13G | filing.txt | 0000315066-20-001577 | 005-91451 | 20953727 | 34 | 8473 | |||
| 2020-05-11 | 10-Q | 10-Q | 0001558370-20-006239 | 001-39231 | 20864785 | 34 | 6181259 | 1 | ||
| 2020-05-11 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-20-059108 | 001-39231 | 20862620 | 34 | 99739 | ||
| 2020-05-07 | 8-K | FORM 8K | 1.01 | 0001104659-20-057763 | 001-39231 | 20854640 | 34 | 20527 | ||
| 2020-04-14 | 8-K | FORM 8-K | 1.01 | 0001104659-20-046098 | 001-39231 | 20789988 | 34 | 28079 | ||
| 2020-04-03 | 8-K | FORM 8-K | 7.01,8.01 | 0001104659-20-042697 | 001-39231 | 20771590 | 34 | 58622 | ||
| 2020-03-27 | 8-K | FORM 8-K | 5.03,9.01 | 0001104659-20-039591 | 001-39231 | 20751796 | 34 | 206785 | ||
| 2020-03-25 | 4 | FORM 4 SUBMISSION | 0001209191-20-021188 | 5017 | ||||||
| 2020-03-13 | 4/A | FORM 4/A SUBMISSION | 0001209191-20-018974 | 11417 | ||||||
| 2020-03-13 | SC 13D | SC 13D | 0001104659-20-033184 | 005-91451 | 20713528 | 34 | 289066 | |||
| 2020-03-12 | 3/A | FORM 3/A SUBMISSION | 0001209191-20-018632 | 5259 | ||||||
| 2020-03-12 | SC 13G | SC 13G | 0001193125-20-071355 | 005-91451 | 20707969 | 34 | 106027 | |||
| 2020-03-09 | SC 13D | SCHEDULE 13D | 0001193125-20-067330 | 005-91451 | 20698868 | 34 | 155851 | |||
| 2020-03-09 | SC 13D | SCHEDULE 13D | 0000947871-20-000199 | 005-91451 | 20698601 | 34 | 117289 | |||
| 2020-03-06 | SC 13G | SCHEDULE 13G | 0001213900-20-005616 | 005-91451 | 20695173 | 34 | 115438 | |||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015675 | 19646 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015670 | 28391 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015666 | 21807 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015661 | 19170 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015654 | 18040 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015648 | 4550 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015640 | 4568 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015634 | 6581 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015629 | 4564 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015628 | 4539 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015626 | 4543 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015623 | 4642 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015621 | 4651 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015619 | 4583 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015618 | 4630 | ||||||
| 2020-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-014706 | 5515 | ||||||
| 2020-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-014704 | 5479 | ||||||
| 2020-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-014702 | 5459 | ||||||
| 2020-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-014700 | 5498 |
One latest value per concept from companyfacts (212 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 3.22M | 2026-11-06 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| dei | EntityNumberOfEmployees | Entity Number of Employees | employee | 27 | 2024-01-31 | 2024 | FY | 10-K | 2025-03-04 | 0001558370-25-002101 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 25.40M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-03 | 0001104659-26-022549 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 618,347 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-07 | 0001104659-26-040130 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 722,565 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-07 | 0001104659-26-040130 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 1.53M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-07 | 0001104659-26-040130 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 1.49M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-07 | 0001104659-26-040130 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 58 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-07 | 0001104659-26-040130 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 1.29 | 2026-09-03 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 2.43 | 2026-09-03 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 17,521.98 | 2026-09-03 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-09-03 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 1.14 | 2026-09-03 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 533,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 2.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 3.92M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 8,000 | 2024-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 724.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 1.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 1.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 129,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 524,265 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 2.64M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | Assets | Assets | USD | 20.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 20.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 9,000 | 2024-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 1,000 | 2024-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 39.17M | 2024-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 7.34M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-04 | 0001558370-24-002310 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 7.30M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-04 | 0001558370-24-002310 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value | USD | 39.18M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-04 | 0001558370-25-002101 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost | USD | 39.17M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-04 | 0001558370-25-002101 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | USD | 39.17M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-04 | 0001558370-25-002101 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 39.18M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-04 | 0001558370-25-002101 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 39.18M | 2024-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 20.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 46.30M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 20.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -26.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 46.30M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 300.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 3.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 3.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 6,000 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-13 | 0001558370-25-007489 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -20.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 17.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | DeferredIncomeTaxLiabilitiesNet | Deferred Income Tax Liabilities, Net | USD | 3.04M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 200,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-03 | 0001558370-21-002287 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 3.20M | 2022-01-01 | 2022 | FY | 10-K | 2023-03-06 | 0001558370-23-002833 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 225.80M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 55.02M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 3.04M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 105.42M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 4.33M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 222.75M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 336,000 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-04 | 0001558370-25-002101 | |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 154,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -6.26 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -2.53 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001558370-21-014460 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -6.26 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.272 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | -0.14 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-04 | 0001558370-25-002101 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | 0.086 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-04 | 0001558370-25-002101 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.025 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 241,000 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.005 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.025 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-04 | 0001558370-25-002101 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.004 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 788,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 1.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 3,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | GainLossOnTerminationOfLease | Gain (Loss) on Termination of Lease | USD | 2.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 15.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 3.37M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 3.50M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestAccrued | Income Tax Examination, Penalties and Interest Accrued | USD | 0 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 12.33M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -9.56M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 4,000 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.16M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 175,000 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | -580,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 3.87M | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-13 | 0001558370-20-010495 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | -693,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 2.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -356,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-03 | 0001558370-21-002287 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 1,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0001558370-22-008859 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 2.27M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0001558370-23-002833 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | 800,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | LeaseCost | Lease, Cost | USD | 1.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 37.30M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 17.42M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 3.76M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 4.20M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 4.08M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 3.97M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 3.86M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 900,000 | 2026-03-31 | S-4 | 2026-07-21 | 0001140361-26-029162 | |||
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 13.29M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | Liabilities | Liabilities | USD | 20.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 20.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 20.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | LitigationReserveCurrent | Estimated Litigation Liability, Current | USD | 1.00M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001558370-24-015431 | |
| us-gaap | LongTermPurchaseCommitmentAmount | Long-term Purchase Commitment, Amount | USD | 2.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | LossContingencyAccrualAtCarryingValue | Loss Contingency Accrual | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | -8,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 14,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 23,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -26.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -20.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-04 | 0001558370-24-002310 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -21.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 581,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 2.50M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0001558370-23-018686 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 24.01M | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 3.57M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 20.44M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | OperatingLeasePaymentsUse | Operating Lease, Payments, Use | USD | 800,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 10.17M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | OtherAssetImpairmentCharges | Other Asset Impairment Charges | USD | 139,000 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | OtherAssetsFairValueDisclosure | Other Assets, Fair Value Disclosure | USD | 139,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001104659-26-022549 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 244,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax | USD | -5,000 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-05 | 0001558370-21-005807 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax | USD | -8,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 2.00M | 2023-12-31 | 2024 | FY | 10-K | 2025-03-04 | 0001558370-25-002101 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 2.00M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0001558370-23-009256 | |
| us-gaap | OtherNoncashExpense | Other Noncash Expense | USD | 14,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 1.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | OtherOperatingIncomeExpenseNet | Other Operating Income (Expense), Net | USD | 4.64M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0001558370-23-018686 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 763,000 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-03 | 0001558370-21-002287 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 338,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0001558370-23-002833 |
| us-gaap | PaymentsToAcquireInProcessResearchAndDevelopment | Payments to Acquire in Process Research and Development | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-04 | 0001558370-24-002310 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 3.00M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-04 | 0001558370-24-002310 |
| us-gaap | PaymentsToAcquireMachineryAndEquipment | Payments to Acquire Machinery and Equipment | USD | 34,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-04 | 0001558370-25-002101 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 88.17M | 2024-01-01 | 2024-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | PaymentsToAcquireProductiveAssets | Payments to Acquire Productive Assets | USD | 34,000 | 2024-01-01 | 2024-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 517,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 3.37M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-05 | 0001558370-21-005807 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 165.81M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0001558370-23-002833 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 8.74M | 2024-01-01 | 2024-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 39.05M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | ProceedsFromSaleOfProductiveAssets | Proceeds from Sale of Productive Assets | USD | 23,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 1.17M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-10 | 0001104659-25-109180 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 35,000 | 2024-01-01 | 2024-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 14,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 8.02M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 4.11M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | PurchaseCommitmentRemainingMinimumAmountCommitted | Purchase Commitment, Remaining Minimum Amount Committed | USD | 10.60M | 2020-04-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001558370-20-013472 | |
| us-gaap | ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff | Research and Development Asset Acquired Other than Through Business Combination, Written-off | USD | 3.00M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-04 | 0001558370-24-002310 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 8.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | Research and Development Expense (Excluding Acquired in Process Cost) | USD | 30.62M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001558370-24-015431 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -724.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 422,000 | 2024-01-01 | 2024-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 1.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.937 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.041 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 200,000 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 322,561 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 36.65 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 200,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-06 | 0001558370-23-002833 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 197,998 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 206,454 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 4.94M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-04 | 0001558370-25-002101 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 254,744 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 5.31 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 302,277 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-03 | 0001558370-22-002719 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 509,265 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 26.56 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 1.04M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-03 | 0001558370-21-002287 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 7.49 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-03 | 0001558370-21-002287 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 509,265 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 26.56 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 302,277 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-03 | 0001558370-22-002719 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 1.08 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-04 | 0001558370-25-002101 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 75.82 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 11.49 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 7 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 50,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.05 | 2025-07-14 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | StockIssuedDuringPeriodSharesReverseStockSplits | Stock Issued During Period, Shares, Reverse Stock Splits | shares | 0 | 2025-07-14 | S-4/A | 2026-09-03 | 0001140361-26-035517 | |||
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 14,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 8.74M | 2024-01-01 | 2024-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 35,000 | 2024-01-01 | 2024-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 81,000 | 2021-01-01 | 2021-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0001558370-22-008859 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 620,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 230.60M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-03 | 0001558370-21-002287 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 2.90M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-09-03 | 0001140361-26-035517 | ||
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 504,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 3.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 53.08M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001558370-21-014460 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 3.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-124783 |